Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| UTI Nifty 50 ETF | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Category | Equity ETFs | Equity ETFs |
| Plan | Direct | Direct |
| Fund house | UTI | Nippon India |
| NAV | ₹283.3922 | ₹29.1708 |
| NAV date | 19 Nov 2026 | 19 Nov 2026 |
| History | 11.2 years | 5.4 years |
| Expense ratio | 0.0% | 0.2% |
| Stars | Not rated | Not rated |
| Growth Score | — | — |
Returns
| UTI Nifty 50 ETF | Nippon India Nifty Pharma ETF | |
|---|---|---|
| 1 month | +11.52% | +10.76% |
| 3 months | +6.06% | +7.79% |
| 6 months | +8.88% | +14.37% |
| YTD | −1.39% | +25.34% |
| 1 year | −1.09% | +25.28% |
| 3 years (CAGR) | +10.11% | +21.97% |
| 5 years (CAGR) | +8.70% | +16.60% |
| 10 years (CAGR) | +13.16% | — |
| Since launch | +12.29% | +14.02% |
Risk
| UTI Nifty 50 ETF | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Volatility | 14.9% | 15.0% |
| Downside volatility | 10.2% | 9.0% |
| Sharpe | 0.24 | 1.03 |
| Sortino | 0.35 | 1.71 |
| Calmar | 0.65 | 1.33 |
| Return / risk | 0.68 | 1.47 |
| Deepest fall | −38.42% | −20.98% |
| Days to recover | 231 | 136 |
| Below its high | −2.14% | −1.80% |
Against benchmark
| UTI Nifty 50 ETF | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Alpha | −0.27% | −0.00% |
| Beta | 0.98 | 1.00 |
| R² | 99.8% | 100.0% |
| Up capture | 98.6% | 100.0% |
| Down capture | 99.9% | 100.0% |
| Tracking error | 0.7% | 0.0% |
| Information ratio | −0.49 | — |
| Treynor | 0.03 | 0.14 |
Consistency
| UTI Nifty 50 ETF | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Best 1-year | +91.39% | +65.21% |
| Middle 1-year | +12.27% | +13.45% |
| Worst 1-year | −32.87% | −15.30% |
| 1-year periods with a loss | 13.5% | 25.8% |
| Middle 3-year | +13.88% | +20.51% |
| Positive months | 61.1% | 61.1% |
| Best day | +3.82% | +3.64% |
| Worst day | −5.85% | −4.03% |
| Worst 5% day | −1.36% | −1.62% |
| Positive days | 52.4% | 54.4% |
| NAVs a year | 248 | 248 |
SIP of ₹10,000 a month
| UTI Nifty 50 ETF | Nippon India Nifty Pharma ETF | |
|---|---|---|
| 5-year XIRR | +8.98% | +20.60% |
| 5-year value | ₹7,55,723 | ₹10,11,201 |
| 3-year XIRR | +5.95% | +19.58% |
| 1-year XIRR | +9.16% | +34.37% |
Holdings overlap i
| UTI Nifty 50 ETF | Nippon India Nifty Pharma ETF | |
|---|---|---|
| UTI Nifty 50 ETF | — | 3% |
| Nippon India Nifty Pharma ETF | 3% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Held by all of them
| Stock | UTI Nifty 50 ETF | Nippon India Nifty Pharma ETF |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 1.76% | 18.61% |
| Dr. Reddy's Laboratories Limited | 0.77% | 8.15% |
| Cipla Limited | 0.73% | 7.67% |
Sectors and company size
| UTI Nifty 50 ETF | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Large companies | — | — |
| Mid companies | — | — |
| Small companies | — | — |
| Top 10 holdings | 53.0% | 78.6% |
| Largest sector | Banks 30% | Pharmaceuticals & Biotechnology 100% |